Lung adenocarcinomas select for expression of a pathway that confers resistance to high oxygen tension and protects cells from ferroptosis; Erastin upregulates p53 and inhibits SLC7A11, which induce ROS accumulation and ferroptosis. Here, TP53 is linked to lung adenocarcinoma.